Biomarkers of manganese intoxication

NeuroToxicology

Volumn 32, Issue 1, 2011, Pages 1-8

  Zheng, Wei ^a   Fu, Sherleen X ^a   Dydak, Ulrike ^a,b   Cowan, Dallas M ^c  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CARDNO CHEMRISK   (United States)

Author keywords

Biomarker; GABA; Iron; Magnetic resonance imaging or MRI; Magnetic resonance spectroscopy or MRS; Manganese; Mn Fe ratio or MIR; Oxidative stress; Positron emission tomography or PET

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 4 AMINOBUTYRIC ACID; ACETYLCHOLINE; BIOLOGICAL MARKER; DOPAMINE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE PEROXIDASE; HOMOVANILLIC ACID; IRON; IRON REGULATORY FACTOR; MANGANESE; PRION PROTEIN; PROLACTIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

BIOACCUMULATION; BLOOD LEVEL; BODY FLUID; BRAIN REGION; BREAST MILK; CELLULAR DISTRIBUTION; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONCENTRATION (PARAMETERS); ENZYME ACTIVITY; FECES LEVEL; HAIR LEVEL; HOMEOSTASIS; HUMAN; INTOXICATION; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LONG TERM EXPOSURE; METAL BINDING; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REVIEW; SKIN; TRACE METAL BLOOD LEVEL; URINE LEVEL;

ANIMALS; BIOLOGICAL MARKERS; BODY FLUIDS; BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MANGANESE; OXIDATIVE STRESS;

EID: 78951484455     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.10.002     Document Type: Review

References (114)

1. Abe Y., Kachi T., Kato T., Ito K., Yanagisawa N., Sobue G. Diagnostic utility of positron emission tomography for parkinsonism after chronic manganese exposure. Rinsho Shinkeigaku 1999, 39:693-699.
2. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicology Profile for Pentachlorophenol TP 93/13. Atlanta: U.S. Department of Health and Human Services; 1994.
3. Alessio L., Apostoli P., Ferioli A., Lombardi S. Interference of manganese on neuroendocrinal system in exposed workers. Preliminary report. Biol Trace Elem Res 1989, 21:249-253.
4. Anantharam V., Kitazawa M., Wagner J., Kaul S., Kanthasamy A.G. Caspase-3-dependent proteolytic cleavage of protein kinase C delta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J Neurosci 2002, 22:1738-1751.
5. Apostoli P., Lucchini R., Alessio L. Are current biomarkers suitable for the assessment of manganese exposure in individual workers?. Am J Ind Med 2000, 37:283-290.
6. Arjona A., Mata M., Bonet M. Diagnosis of chronic manganese intoxication by magnetic resonance imaging. N Engl J Med 1997, 336:964-965.
7. Aschner M., Aschner J.L. Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci Biobehav Rev 1991, 15:333-340.
8. Aschner M., Guilarte T.R., Schneider J.S., Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 2007, 221:131-147.
9. Aschner M., Erikson K.M., Hernández E.H., Tjalkens R. Manganese and its role in Parkinson's disease: from transport to Neuropathology. Neuromol Med 2009, 11:252-266.
10. Bader M., Dietz M.C., Ihrig A., Triebig G. Biomonitoring of manganese in blood, urine and axillary hair following low-dose exposure during the manufacture of dry cell batteries. Int Arch Occup Environ Health 1999, 72:521-527.
11. Barbeau A., Inoue N., Cloutier T. Role of manganese in dystonia. Adv Neurol 1976, 14:339-352.
12. Bauman J.W., Liu J., Liu Y.P., Klaassen C.D. Increase in metallothionein produced by chemicals that induce oxidative stress. Toxicol Appl Pharmacol 1991, 110:347-354.
13. Calne D.B., Chu N.S., Huang C.C., Lu C.S., Olanow W. Manganism and idiopathic Parkinson's disease: similarities and differences. Neurology 1994, 44:1583-1586.
14. Chang Y., Woo S.T., Lee J.J., Song H.J., Lee H.J., Yoo D.S., et al. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy. Neurotoxicology 2009, 30:950-957.
15. Chang Y., Woo S.T., Kim Y., Lee J.J., Song H.J., Lee H.J., et al. Pallidal index measured with three-dimensional T1-weighted gradient echo sequence is a good predictor of manganese exposure in welders. J Magn Reson Imaging 2010, 31:1020-1026.
16. Chen M.T., Yiin S.J., Sheu J.Y., Huang Y.L. Brain lipid peroxidation and changes of trace metals in rats following chronic manganese chloride exposure. J Toxicol Environ Health A 2002, 65:305-316.
17. Chen J.Y., Tsao G., Zhao Q., Zheng W. Differential cytotoxicity of Mn(II) and Mn(III): special reference to mitochondrial [Fe-S] containing enzymes. Toxicol Appl Pharmacol 2001, 175:160-168.
18. Choi C.J., Anantharam V., Martin D.P., Nicholson E.M., Richt J.A., Kanthasamy A., et al. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease. Toxicol Sci 2010, 115:535-546.
19. Cowan D.M., Fan Q., Zou Y., Shi X., Chen J., Aschner M., et al. Manganese exposure among smelting workers: blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers 2009, 14:3-16.
20. Cowan D.M., Zheng W., Zou Y., Shi X., Chen J., Rosenthal F.S., et al. Manganese exposure among smelting workers: relationship between blood manganese-iron ratio and early onset neurobehavioral alterations. Neurotoxicology 2009, 30:1214-1222.
21. Dietz M.C., Ihrig A., Wrazidlo W., Bader M., Jasen O., Triebig G. Results of magnetic resonance imaging in long-term manganese dioxide-exposed workers. Env Res 2001, 85:37-40.
22. Dobson A.W., Weber S., Dorman D.C., Lash L.K., Erikson K.M., Aschner M. Inhaled manganese sulfate and measures of oxidative stress in rat brain. Biol Trace Elem Res 2003, 93:113-126.
23. Dobson A.W., Weber S., Dorman D.C., Lash L.K., Erikson K.M., Aschner M. Oxidative stress is induced in the rat brain following repeated inhalation exposure to manganese sulphate. Biol Trace Elem Res 2003, 93:113-126.
24. Donaldson J. The physiopathologic significance of manganese in the brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 1987, 3:451-462.
25. Dorman D.C., McManus B.E., Marshall M.W., James R.A., Struve M.F. Old age and gender influence the pharmacokinetics of inhaled manganese sulphate and manganese phosphate in rats. Toxicol Appl Pharmacol 2004, 197:113-124.
26. Dorman D.C., Struve M.F., Marshall M.W., Parkinson C.U., James R.A., Wong B.A. Tissue manganese concentrations in young male rhesus monkeys following subchronic manganese sulphate inhalation. Toxicol Sci 2006, 92:201-210.
27. Dorman D.C., Struve M.F., Wong B.A., Dye J.A., Robertson I.D. Correlation of brain magnetic resonance imaging changes with pallidal manganese concentrations in rhesus monkeys following subchronic manganese inhalation. Toxicol Sci 2006, 92:219-227.
28. Dydak U, Jiang YM, Long LL, Zhu H, Chen J, Li WM, et al. In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Env Health Persp.,[in press]. doi:10.1289/ehp.1002192.
29. Edmé J.L., Shirali P., Mereau M., Sobazek A., Boilenguez C., Diebold F., et al. Assessment of biological chromium among stainless steel and mild steel welders in relation to welding processes. Int Arch Occup Environ Health 1997, 70:237-242.
30. Ellingsen D.G., Haug E., Ulvik R.J., Thomassen Y. Iron status in manganese alloy production workers. J Appl Toxicol 2003, 23:239-247.
31. Erikson K.M., Tedroff J., Thuomas K.A., Aquilonius S.M., Hartvig P., Fasth K.J., et al. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch Toxicol 1992, 66:403-407.
32. Erikson K.M., Dobson A.W., Dorman D.C., Aschner M. Manganese exposure and induced oxidative stress in the rat brain. Sci Total Environ 2004, 334-335:409-416.
33. Erikson K.M., Dorman D.C., Fitsanakis V., Lash L.H., Aschner M. Alterations of oxidative stress biomarkers due to in utero and neonatal exposures of airborne manganese. Biol Trace Elem Res 2006, 111:199-215.
34. Fowle J.R., Sexton K. EPA priorities for biologic markers research in environmental health. Environ Health Persp 1992, 98:235-241.
35. Guilarte T.R. Manganese and Parkinson's disease: a critical review and new findings. Environ Health Persp 2010, 118:1071-1080.
36. Guilarte T.R., McGlothan J.L., Degaonkar M., Chen M.K., Barker P.B., Syversen T., et al. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol Sci 2006, 94:351-358.
37. HaMai D., Campbell A., Bondy S.C. Modulation of oxidative events by multivalent manganese complexes in brain tissue. Free Radic Biol Med 2001, 31:763-768.
38. Huang C.X., Cao C.G. Analysis of hair manganese concentration of 807 welders. J Henan Univ Sci Technol (Med Sci) 2003, 21:278-279.
39. Husain M., Khanna V.K., Roy A., Tandon R., Pradeep S., Set P.K. Platelet dopamine receptors and oxidative parameters as markers of manganese toxicity. Hum Exp Toxicol 2001, 20:631-636.
40. Jiang Y.M., Mo X.A., Du F.Q., Fu X., Zhu X.Y., Gao H.Y., et al. Effective treatment of manganese-induced occupational parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study. J Occup Environ Med 2006, 48:644-649.
41. Jiang Y.M., Zheng W., Long L.L., Zhao W.J., Li X.R., Mo X.A., et al. Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. Neurotoxicology 2007, 28:126-135.
42. Jiang Y.M., Long L.L., Zhu X.Y., Zheng H., Fu X., Ou S.Y., et al. Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Toxicol Lett 2008, 181:118-125.
43. Josephs K.A., Ahlskog J.E., Klos K.J., Kumar N., Fealey R.D., Trenerry M.R., et al. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005, 64:2033-2039.
44. Kägi J.H.R. Evolution, structure and chemical activity of class I metallothioneins: an overview. Metallothionein III, Biological Roles and Medical Implications 1993, 29-55. Birkhäuser Verlag, Basel, Switzerland. K.T. Suzuki, N. Imura, M. Kimura (Eds.).
45. Keen C.L., Clegg M.S., Lönnerdal B., Hurley L.S. Whole-blood manganese as an indicator of body manganese. New Engl J Med 1983, 308:1230.
46. Kim E.A., Cheong H.K., Choi D.S., Sakong J., Ryoo J.W., Park I.J., et al. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings. Neurotoxicology 2007, 28:276-283.
47. Kim J.M., Kim J.S., Jeong S.H., Kim Y.K., Kim S.E., Kim S.H., et al. Dopaminergic neuronal integrity in parkinsonism associated with liver cirrhosis. Neurotoxicology 2010, 31(4):351-355.
48. Kim S.H., Chang K.H., Chi J.G., Cheong H.K., Kim J.Y., Kim Y.M., et al. Sequential change of MR signal intensity of brain after manganese administration in rabbits. Correlation with manganese concentration and histopathologic findings. Invest Radiol 1999, 34:383-393.
49. Kim Y., Kim J.W., Ito K., Lim H.S., Cheong H.K., Kim J.Y., et al. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology 1999, 20:249-252.
50. Kim Y., Kim K.S., Yang J.S., Shin Y.C., Park I.J., Kim E., et al. Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. Neurotoxicology 1999, 20:901-907.
51. Kim Y. High signal intensities on T1-weighted MRI as a biomarker of exposed to manganese. Ind Health 2004, 42:111-115.
52. Kitazawa M., Anantharam V., Yang Y., Hirata Y., Kanthasamy A., Kanthasamy A.G. Activation of protein kinase Cδ by proteolytic cleavage contributes to manganese-induced apoptosis in dopaminergic cells: protective role of Bcl-2. Biochem Pharmacol 2005, 69:133-146.
53. Krieger D., Krieger S., Jansen O., Gass P., Theilmann L., Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995, 346:279-284.
54. Latchoumycandane C., Anantharam V., Kitazawa M., Yang Y.J., Kanthasamy A., Kanthasamy A.G. Protein kinase Cδ is a key downstream mediator of manganese-induced apopotosis in Dopaminergic Neuronal Cells. J Pharmacol Exp Therapeutics 2005, 313:46-55.
55. Li G.J., Zhang L.L., Lu L., Wu P., Zheng W. Occupational exposure to welding fume among welders: alterations of manganese, iron, zinc, copper, and lead in body fluids and the oxidative stress status. J Occup Environ Med 2004, 46:241-248.
56. Li G.J., Zhao Q.Q., Zheng W. Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro. Toxicol Appl Pharmacol 2005, 205:188-200.
57. Liccione J.J., Maines M.D. Selective vulnerability of glutathione metabolism and cellular defence mechanisms in rat striatum to manganese. J Pharmacol Exp Ther 1988, 247:156-161.
58. Lin F.Y. Significances of the analysis of hair manganese concentration of welders. Chin J Public Health Manage 2002, 18:87.
59. Long L.L., Li X.R., Huang Z.K., Jiang Y.M., Fu S.X., Zheng W. Relationship between changes in brain MRI and (1)H-MRS, severity of chronic liver damage, and recovery after liver transplantation. Exp Biol Med (Maywood) 2009, 234:1075-1085.
60. Lucchini R., Apostoli P., Perrone C., Placidi D., Albini E., Migliorati P., et al. Long-term exposure to "low levels" of manganese oxides and neurofuctional changes in ferroalloy workers. Neurotoxicology 1999, 20:287-297.
61. Lucchini R., Albini E., Placidi D., Gasparotti R., Pigozzi M.G., Montani G., et al. Brain magnetic resonance imaging and manganese exposure. Neurotoxicology 2000, 21:769-775.
62. Lu L., Zhang L.L., Li G.J., Guo W., Liang W., Zheng W. Alteration of serum concentrations of manganese, iron, ferritin, and transferitin receptor following exposure to welding fumes among career welders. Neurotoxicology 2005, 26:257-265.
63. Mena I., Marin O., Fuenzalida S., Cotzias G.C. Chronic manganese poisoning: clinical picture and manganese turnover. Neurology 1967, 17:128-136.
64. Meister A., Anderson M.E. Glutathione. Ann Rev Biochem 1984, 52:711-760.
65. Misiewicz A., Radwan K., Misiewicz A., Dziewit T. Malonyl dialdehyde concentration in red blood cells of workers engaged in the production of iron manganese alloys. Med Pr 1999, 50:277-281.
66. Misselwitz B., Mühler A., Weinmann H.J. A toxicologic risk for using manganese complexes? A literature survey of existing data through several medical specialties. Invest Radiol 1995, 30:611-620.
67. Morgan M. Cerebral magnetic resonance imaging in patients with chronic liver disease. Metab Brain Dis 1998, 13:273-280.
68. Myers J.E., Thompson M.L., Naik I., Theodorou P., Esswein E., Tassell H., et al. The utility of biological monitoring for manganese in ferroalloy smelter workers in South Africa. Neurotoxicology 2003, 24:875-883.
69. Mutti A., Bergamaschi E., Alinovi R., Lucchini R., Vettori M.V., Franchini I. Serum prolactin in subjects occupationally exposed to manganese. Ann Clin Lab Sci 1996, 26:10-17.
70. Mutti A., Smargiassi A. Selective vulnerability of dopaminergic systems to industrial chemicals: risk assessment of related neuroendocrine changes. Toxicol Ind Health 1998, 14:311-323.
71. NRC Biologic markers in reproductive toxicology. National Academy of Sciences/National Research Council 1989, National Academy Press, Washington, DC, p. 15-35.
72. 109Cd gamma-ray induced K-XRF bone lead measurement system. Phys Med Biol 2006, 51:351-360.
73. Nelson K., Golnick J., Korn T., Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 1993, 50:510-513.
74. Newland M.C., Cox C., Hamada R., Oberdorster G., Wess B. The clearance of manganese chloride in the primates. Fundam Appl Toxicol 1987, 9:314-328.
75. Newland M.C., Ceckler T.L., Kordower J.H., Weiss B. Visualizing manganese in the primate basal with magnetic resonance imaging. Exp Neurol 1989, 106:251-258.
76. Newland M.C. Animal models of manganese's neurotoxicity. Neurotoxicology 1999, 20:415-432.
77. Oda T., Akaike T., Hamamoto T., Suzuki F., Hirano T., Maeda H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 1989, 244:974-976.
78. Olanow C.W. Mn-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci 2004, 1012:209-223.
79. Ono K., Komai K., Yamada M. Myoclonic involuntary movement associated with chronic manganese poisoning. J Neurol Sci 2002, 199:93-96.
80. Oubrahim H., Stadtman E.R., Chock P.B. Mitochondria play no roles in Mn(II)-induced apoptosis in Hela cells. Proc Natl Acad Sci U S A 2001, 98:9505-9510.
81. Park J.D., Chuang Y.H., Kim C.Y., Ha C.S., Yang S.O., Khang H.S., et al. Comparison of high MRI T1 signals with manganese concentration in brains of cynomolgus monkeys after 8 months of stainless steel welding-fume exposure. Inhal Toxicol 2007, 19:965-971.
82. Park R., Bowler R., Eggerth D., Diamond e, Spencer K., Smith D.R., et al. Issues in neurological risk assessment for occupational exposures: The Bay Bridge Welders. Neurotoxicology 2006, 27:373-384.
83. Pujol A., Pujol J., Graus F., Rimola A., Peri J., Mercader J.M., et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993, 43:65-69.
84. 18F] FDOPA PET and clinical features in Parkinsonism due to manganism. Movement Disorders 2005, 20:492-496.
85. Roels H.A., Ghyselen P., Buchet J.P., Ceulemans E., Lauwerys R.R. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med 1992, 49:25-34.
86. 2) on the absorption and cerebral distribution of manganese in rats. Arch Toxicol 1997, 71:223-230.
87. Sadek A.H., Rauch R., Schulz P.E. Parkinsonism due to manganism in a welder. Int J Toxicol 2003, 22:393-401.
88. Saleem K.S., Pauls J.M., Augath M., Trinath T., Prause B.A., Hashikawa T., et al. Magnetic resonance imaging of neuronal connections in the macaque monkey. Neuron 2002, 34:685-770.
89. Salehi F., Krewski D., Mergler D., Normandin L., Kennedy G., Philippe S., et al. Bioaccumulation and locomotor effects of manganese phosphate/sulphate mixture in Sprague-Dawley rats following subchronic (90 days) inhalation exposure. Toxicol Appl Pharmacol 2003, 19:264-271.
90. Sato K., Ueyama H., Arakawa R., Kumamoto T., Tsuda T. A case of welder presenting with parkinsonism after chronic manganese exposure. Rinsho Shinkeigaku 2000, 40:1110-1115.
91. Schroeder H.A., Balassa J.J., Tipton I.H. Essential trace metals in man: manganese. A study in homeostasis. J Chronic Dis 1966, 19:545-571.
92. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994, 36:356-361.
93. Shinotoh H., Snow B.J., Hewitt K.A., Pate B.D., Doudet D., Nugent R., et al. MRI and PET studies of manganese-intoxicated monkeys. Neurology 1995, 45:1199-1204.
94. Sloot W.N., Korf J., Koster J.F., DeWit L.E.A., Gramsbergen J.B.P. Manganese-induced hydroxyl radical formation in rat striatum is not attenuated by dopamine depletion or iron chelation in vivo. Exp Nurol 1996, 138:236-245.
95. Smargiassi A., Mutti A. Peripheral biomarkers and exposure to manganese. Neurotoxicology 1999, 20:401-406.
96. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: implication for Parkinson's disease. Proc Natl Acad Sci 1989, 87:1398-1400.
97. Sung J.H., Kim C.H., Yang S.O., Khang H.S., Cheong H.K., Lee J.S., et al. Changes in blood manganese concentration and MRI T1 relaxation time during 180 days of stainless steel welding-fume exposure in cynomolgus monkeys. Inhal Toxicol 2007, 19:47-55.
98. Suzuki K.T., Imura N., Kimura M. Metallothionein III. Biological Roles and Medical Implications 1993, Birkhäuser Verlag, Basel, Switzerland.
99. Takeda A. Manganese action in brain function. Brain Res Rev 2003, 41:79-87.
100. Takeda A., Sawashita J., Okada S. Biological half-lives of zinc and manganese in rat brain. Brain Res 1995, 695:53-58.
101. Tapin D., Kennedy G., Lamber J., Zayed J. Bioaccumulation and locomotor effects of manganese sulphate in Sprague-Dawley rats following subchronic (90 days) inhalation exposure. Toxicol Appl Pharmacol 2006, 211:166-174.
102. Ulrich C.E., Rinehart W., Brandt M. Evaluation of the chronic inhalation toxicity of a manganese oxide aerosol. III. Pulmonary function, electromyograms, limb tremor, and tissue manganese data. Am Ind Hyg Assoc 1979, 40:349-353.
103. Vasak M., Kägi J.H.R. Encyclopedia of Inorganic Chemistry 1994, 2229-2241. John Wiley and Sons Ltd, New York. R.B. King (Ed.).
104. Wang D.X., Du X.Q., Zheng W. Alteration of saliva and serum concentrations of manganese, copper, zinc, cadmium and lead among career welders. Toxicol Lett 2008, 176:40-47.
105. Wang S.H., Wu J. The significances of hair manganese concentration detection in general investigation of manganism. Neimenggu Prevent Med 2000, 25:145-146.
106. Wolters E.C., Huang C.C., Clark C., Peppard R.F., Okada J., Chu N.S., et al. Positron emission tomography in manganese intoxication. Ann Neurol 1989, 26:647-651.
107. Wongwit W., Kaewhungwal J., Chantachum Y., Visesmanee V. Comparison of biological specimens for manganese determination among highly exposed welders. Southeast Asian J Trop Med Public Health 2004, 35:764-769.
108. Xie P.Y., Lei Z.L., Yin X.X., Liu W.N., Yang D.P., Chen L.H. The investigation of the relationship between occupational manganese exposure and urine and hair manganese concentrations. Chin J Ind Med 1995, 8:202-205.
109. Zhang Y., Zhang H.X., Wan G.M., Jiang L.J. The investigation of the relationship between hair manganese concentration and occupational intoxication. Stud Trace Elem Health 1996, 13(2):45-46.
110. Zheng W., Zhao Q. Iron overload following manganese exposure in cultured neuronal, but not neuroglial cell. Brain Res 2001, 897:175-179.
111. Zheng W., Jiang Y.M., Zhang Y.S., Jiang W., Wang X., Cowan D.M. Chelation Therapy of manganese intoxication by para-aminosalicylic acid (PAS) in Sprague-Dawley rats. Neurotoxicology 2009, 30:240-248. 10.1016/j.neuro.2008.12.007.
112. Zheng W., Kim H., Zhao Q. Comparative toxicokinetics of manganese chloride and methylcyclo-pentadienyl Mn tricarbonyl in male Sprague-Dawley rats. Toxicol Sci 2000, 54:295-301.
113. Zheng W., Ren S., Graziano J.H. Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res 1998, 799:334-342.
114. Zheng W., Zhao Q., Slavkovich V., Aschner M., Graziano J.H. Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res 1999, 833:125-132.